These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12376059)

  • 1. Advances in Burkholderia cepacia complex.
    Speert DP
    Paediatr Respir Rev; 2002 Sep; 3(3):230-5. PubMed ID: 12376059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.
    Mahenthiralingam E; Coenye T; Chung JW; Speert DP; Govan JR; Taylor P; Vandamme P
    J Clin Microbiol; 2000 Feb; 38(2):910-3. PubMed ID: 10655415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
    Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
    Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas.
    Jones AM; Dodd ME; Webb AK
    Eur Respir J; 2001 Feb; 17(2):295-301. PubMed ID: 11334134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.
    Fiore A; Laevens S; Bevivino A; Dalmastri C; Tabacchioni S; Vandamme P; Chiarini L
    Environ Microbiol; 2001 Feb; 3(2):137-43. PubMed ID: 11321544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.
    Crowley D; Daly M; Lucey B; Shine P; Collins JJ; Cryan B; Moore JE; Murphy P; Buckley G; Fanning S
    J Appl Microbiol; 2002; 92(5):992-1004. PubMed ID: 11972706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis.
    Chen JS; Witzmann KA; Spilker T; Fink RJ; LiPuma JJ
    J Pediatr; 2001 Nov; 139(5):643-9. PubMed ID: 11713440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
    Bernhardt SA; Spilker T; Coffey T; LiPuma JJ
    Clin Infect Dis; 2003 Sep; 37(6):780-5. PubMed ID: 12955638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
    Henry DA; Mahenthiralingam E; Vandamme P; Coenye T; Speert DP
    J Clin Microbiol; 2001 Mar; 39(3):1073-8. PubMed ID: 11230429
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Narayanaswamy VP; Duncan AP; LiPuma JJ; Wiesmann WP; Baker SM; Townsend SM
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910901
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
    Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J
    J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.
    Kidd TJ; Bell SC; Coulter C
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):434-7. PubMed ID: 12884074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.
    Agodi A; Mahenthiralingam E; Barchitta M; Gianninò V; Sciacca A; Stefani S
    J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.
    LiPuma JJ; Spilker T; Gill LH; Campbell PW; Liu L; Mahenthiralingam E
    Am J Respir Crit Care Med; 2001 Jul; 164(1):92-6. PubMed ID: 11435245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.